Four oncology-services deals probed simultaneously by Australian competition watchdog

Cancer services provider Icon Group has found itself at the center of a regulatory storm, after Australia’s competition watchdog today announced four parallel reviews into various deals proposed by the company....

Already a subscriber? Click here to view full article